Deborah Dukovic

1.0k citations
17 papers · 767 · 1 hit paper · h-index 6

Impact in

Papers in

Deborah Dukovic

17 papers receiving 744 citations

Deborah Dukovic's Hit Papers

Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial 2014 · 406 citations
4060+4+8Years since publication100200300400

Peers

Deborah Dukovic
Comparison fields: 5 of 72
  • Pathology and Forensic Medicine 405
  • Neurology 135
  • Rheumatology 88
  • Neurology 46
  • Oncology 145
Replace Xiaojun You with:
Xiaojun You United States
Orla Tuohy United Kingdom
Kaiying Yang China
Aylar Poyraz Türkiye
A. M�ller Germany
Hisae Ichida Japan
Amit Allahabadia United Kingdom
Michio Ozeki Japan
Ajay Ajmani United States
Walter Josef Faßbender Germany
Deborah Dukovic relative to Xiaojun You United States Xiaojun You's profile →
Citations per field
00.5×3.3×
Xiaojun You · 1×
Citations per year

Countries citing papers authored by Deborah Dukovic

Since Specialization
Citations

This map shows the geographic impact of Deborah Dukovic's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Dukovic with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Dukovic more than expected).

Fields of papers citing papers by Deborah Dukovic

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Dukovic. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Dukovic. The network helps show where Deborah Dukovic may publish in the future.

Co-authors

The 25 scholars most cited alongside Deborah Dukovic, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Deborah Dukovic Line = papers co-authored together Deborah Dukovic links everyone, so they are left out of the graph.

All Works

17 of 17 papers shown
#Work
1
Oral teriflunomide for patients with relapsing multiple sclerosis (TOWER): a randomised, double-blind, placebo-controlled, phase 3 trial
Hit paper breakdown →
2014406
2 2004253
3 201561
4 201212
5 19949
6 19955
7 20215
8 20153
9 20143
10 20152
11 20142
12 20251
13 20141
14 20141
15 20141
16 20151
17 20171

About Deborah Dukovic

Deborah Dukovic is a scholar working on Pathology and Forensic Medicine, Rheumatology, Immunology, Pharmacology and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 767 indexed citations. Recurring topics across this work include Multiple Sclerosis Research Studies (7 papers), Immunodeficiency and Autoimmune Disorders (3 papers), Urticaria and Related Conditions (3 papers), Polyomavirus and related diseases (2 papers), Drug-Induced Adverse Reactions (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Fungal Plant Pathogen Control (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (405 citations), Neurology (135 citations), Rheumatology (88 citations), Neurology (46 citations) and Oncology (145 citations). Deborah Dukovic has collaborated with scholars based in United States, France and Canada. Frequent co-authors include Philippe Truffinet, Tomas Olsson, Ludwig Kappos, Aaron Miller, Mark Freedman, Jerry S. Wolinsky, Paul O’Connor, Werner Hacke, Armin Grau and Tobias Brandt. Their work appears in journals such as Neurology, Multiple Sclerosis and Related Disorders, Investigative Radiology, Stroke and Academic Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact